Braidwell »

Insulet Corp shares owned by Braidwell

Quarter-by-quarter ownership of Insulet Corp shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Insulet Corp

Tip: Access up to 7 years of quarterly data

All positions including Insulet Corp held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insulet Corp by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $73M 63M 1.15
2023-09-30 $54M 55M 0.98

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Insulet Corp

Tenor Capital Management
Franklin Resources
Braidwell
Calamos Advisors
Lazard Asset Management
Wellington Management Company
D. E. Shaw & Co
Wells Fargo & Company
Segantii Capital Management
Alberta Investment Management Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management
Millennium Management
RWC Asset Management
SSI Investment Management

View all funds holding Insulet Corp